Stocks in Sweden finished the trading day lower on Thursday, with the benchmark OMX Stockholm 30 index ending down 0.69% at the close in Stockholm. Sector pressure from Oil & Gas, Basic Materials and Industrials was cited as the primary driver behind the overall decline.
Among individual names on the OMX Stockholm 30, NIBE Industrier AB ser. B (ST:NIBEb) recorded the largest gain, climbing 5.59% or 2.10 points to close at 38.90. Essity AB B (ST:ESSITYb) added 2.52% or 7.00 points to finish at 284.40, and AstraZeneca PLC (ST:AZN) rose 1.62% or 29.00 points to 1,815.00 in late trade.
On the downside, Evolution AB (ST:EVOG) fell 4.18% or 23.40 points to end at 536.60, marking a move down to 5-year lows for the stock. SAAB AB ser. B (ST:SAABb) declined 2.44% or 15.70 points to 627.70, while Boliden AB (ST:BOL) was down 2.21% or 14.60 points to 646.20.
Market breadth on the Stockholm exchange showed more decliners than advancers, with 469 stocks falling versus 274 that advanced, and 68 finishing unchanged.
Commodity markets moved lower alongside equities. Crude oil for March delivery dropped 2.86% or 1.85 to $62.78 a barrel. Brent oil for April delivery declined 2.78% or 1.93 to $67.47 a barrel. In metals, the April Gold Futures contract fell 2.38% or 121.56 to trade at $4,976.94 a troy ounce.
Currency moves against the Swedish krona included EUR/SEK rising 0.45% to 10.60 and USD/SEK increasing 0.45% to 8.93. The US Dollar Index Futures was up 0.10% at 96.82.
The session presented a mix of divergent large-cap performance and broader sector weakness: several defensive or industrial names outperformed, while resource-linked and defence-related stocks were among the heaviest decliners. Notable firm-level moves included Evolution AB's slide to 5-year lows and AstraZeneca reaching an all-time high at 1,815.00.
These developments occurred amid declines in crude oil and Brent and a notable drop in the April Gold Futures contract, while the krona weakened modestly versus both the euro and the dollar.